Ancora Pharmaceuticals
About
Scientific Advisory Board
Technology Applications
Overview: Why Synthetic Carbohydrates?
Vaccine Pipeline
Press Room
Blog
Contact
Ancora in the News
MIT News Office
:
Ancora Pharmaceuticals takes top prize in $50K business plan contest
bNet
:
Surface Logix and Ancora Pharmaceuticals Awarded $6.9 Million NIST-ATP Grant to Develop New Drug Discovery Technologies Based On Carbohydrates
bNet
: MIT Biomedical Innovation Forum to Address the Future of Vaccines and Central Nervous System Disorders Through the Lens of Personalized Medicine
Nano Science and Technology Institute
: Harris & Harris Group Invests in Ancora Pharmaceuticals
Nanotechnology Now
:
Harris & Harris Group Invests in Ancora Pharmaceuticals
The Tech
:
Ancora Pharmaceuticals Triumphs in $50K Contest
Chemistry & Biology
:
Ancora Cooks with Carbs Synthesizing Carbohydrate Vaccines
Chemical & Engineering News
: Founder Of Ancora Wins Korber Prize
Chemical & Engineering News
:
Carbohydrate Vaccines
Chemical & Engineering News
: Preventing Malaria
Chemical & Engineering News
:
Carbohydrate Advances
Chemical & Engineering News
:
2003 ACS Cope Award Winners
Chemical Biology
: Interview with Peter Seeberger
Medical News Today
: Potential Vaccine Developed For Deadly Leishmaniasis Disease
Mass High Tech
: Ancora anchors drug plans with $2.2M in VC
Recent Posts
New-Generation Diabetes Drugs Review
Categories
Genetal Health
© 2023 www.ancorapharma.com. All rights reserved.